spacer
home > ict > summer 2019 > therapeutic oncology and the road ahead
PUBLICATIONS
International Clinical Trials

Therapeutic Oncology and the Road Ahead




ICT: What trends are you seeing in therapeutic oncology?

Dr Tim Williams: We are seeing significant interest in the application of remote, digital patient-reported outcomes measurement (PROMs) to enhance routine cancer care in the UK. There is growing awareness of the importance in quality of life as more people live with and beyond cancer, as well as a drive for new approaches to support cancer service delivery and better care for patients over the long term, focusing on acute treatment at a time when the workforce faces increased pressure.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
About the author


Dr Tim Williams is the Co-Founder and CEO of My Clinical Outcomes (MCO), a clinical technology platform that automates the collection and analysis of PROMs in routine clinical practice. Tim previously worked as an NHS doctor and Strategy Consultant and has a keen interest in how technology can help improve healthcare services. MCO is in use at over 70 UK public and private hospitals in a range of conditions and specialties and is now working on several innovative projects helping to support the care of cancer patients in the NHS.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Business Continuity Plan - Message from Protagen Protein Services (PPS)

Following the recent COVID-19 outbreak, we at Protagen Protein Services (PPS) are preparing for all eventualities. Please be assured that PPS will continue to operate as normal providing you with all of the professional support and service you have to come to expect from us. Given the gravity of the situation, and to protect our staff, clients, and communities from the spread of the virus, we have taken various measures within a scope of a Business Continuity Plan:
More info >>

White Papers

Migration safe pharmaceutical labels improve patient safety

UPM Raflatac

Labels play an invaluable role on pharmaceutical packages. Pharmaceutical companies should only use labels that meet low-leachability and extraction requirements. Labels that are not migration safe, e.g. create leachable chemical compounds, may fail testing and result in significant launch delays or costly recalls. This white paper presents how pharmaceutical companies can ensure that the final label constructions achieve their business, regulatory and patient safety goals.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement